Cover
Cover | May 01, 2023 |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 01, 2023 |
Entity File Number | 001-37353 |
Entity Registrant Name | BIONDVAX PHARMACEUTICALS LTD. |
Entity Central Index Key | 0001611747 |
Entity Tax Identification Number | 00-0000000 |
Entity Incorporation, State or Country Code | L3 |
Entity Address, Address Line One | Jerusalem BioPark |
Entity Address, Address Line Two | 2nd Floor |
Entity Address, Address Line Three | Hadassah Ein Kerem Campus |
Entity Address, City or Town | Jerusalem |
Entity Address, Country | IL |
Entity Address, Postal Zip Code | 00000 |
City Area Code | 972 |
Local Phone Number | 8-930-2529 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Entity Information, Former Legal or Registered Name | Not Applicable |
American Depositary Shares, each representing 400 Ordinary Shares, no par value | |
Title of 12(b) Security | American Depositary Shares, each representing 400 Ordinary Shares, no par value |
Trading Symbol | BVXV |
Security Exchange Name | NASDAQ |
Ordinary Shares, no par value | |
Title of 12(b) Security | Ordinary Shares, no par value |
Security Exchange Name | NASDAQ |